← All stocks

NextCure, Inc.

NXTC Net buying
CIK 0001661059 #4911 in the set updated 17 Sep 2026
Bought (120 mo)
$27.10M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$184.80K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$184.80K
1 of 1 sales
Net
+$26.91M
+$26.91M against sales at will

By person

11 insiders · 24 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Sofinnova Venture Partners IX, L.P. entity
10% owner
$11.51M (2)
+$11.51M
2,671,856
$16.46M
Khuong Chau Quang
Director
$5.25M (1)
+$5.25M
2,711,013
$16.70M
ORBIMED ADVISORS LLC entity
Director
$5.25M (1)
+$5.25M
2,711,013
$16.70M
Xu Stella
Director
$1.88M (1)
+$1.88M
1,103,570
$6.80M
ADAR1 Capital Management, LLC entity
10% owner
$1.71M (13)
+$1.71M
722,419
$4.45M
+92.3%
CANAAN X L.P.
10% owner
$750.00K (1)
+$750.00K
2,254,442
$13.89M
SHANNON TIMOTHY M
Director
$750.00K (1)
+$750.00K
2,254,442
$13.89M
Simcere Zaiming, Inc. entity
Former 10% Owner
$184.80K (1)
−$184.80K
308,636
$1.90M
−8.9%
Alexandria Venture Investments, LLC entity
10% owner
197,993
$1.22M
Liu Linda
SVP, Research
55,234
$340.24K
Heller Kevin N.
Chief Medical Officer
49,011
$301.91K
+125.0%

No percentages here. This company's share count has moved by a factor of 10.5 over the window, from 2,676,110 to 28,050,191 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Simcere Zaiming, Inc.
10 Aug 2026
Former 10% Owner
Sell indirect
30,000
$6.16
$184.80K

What was left out

Form 4 filings counted 127
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 12,511,792
History held since 13 May 2019